Related Experiment Video
Updated: Feb 15, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Cancer immunotherapy in 2017: The breakthrough of the microbiota
Guido Kroemer1, Laurence Zitvogel2
1Equipe 11 labellisée par la Ligue contre le Cancer, Centre de Recherche des Cordeliers; Paris, France; Cell Biology and Metabolomics platforms, Gustave Roussy Cancer Campus; Villejuif, France; INSERM U1138, Paris, France; Université Paris Descartes, Sorbonne Paris Cité; Paris, France; Université Pierre et Marie Curie, Paris, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France; and Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.
No abstract available in PubMed .
Related Concept Videos
Tumor Immunotherapy
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

